IKS Health Acquires TruBridge for $565 Million to Expand US Healthcare Presence

Inventurus Knowledge Solutions Ltd to Acquire TruBridge Inc. in $565 Million Deal

Mumbai-based healthcare technology services company Inventurus Knowledge Solutions Ltd (IKS Health) has agreed to acquire US-based healthcare technology firm TruBridge Inc. for a total consideration of up to $565 million. This acquisition marks IKS Health's largest deal to date and a strategic push into rural and community hospital technology.

The acquisition, announced after market hours, will see IKS Health buy 100% of TruBridge through its US arm, Inventurus Knowledge Solutions Inc. The deal is aimed at strengthening IKS Health's footprint across electronic health records (EHR) and revenue cycle management (RCM) for smaller hospitals in the US.

Under the terms of the agreement, TruBridge shareholders will receive $26.25 in cash per share, valuing the Nasdaq-listed company at an enterprise value of about $557 million. The transaction is expected to be completed within 180 days, subject to customary regulatory and shareholder approvals.

Read also: KKR-Backed Renewable Energy Firm Re Enters High-Stakes Sale Process

The acquisition will help diversify IKS Health's business into a sticky, recurring SaaS-led EHR segment, while allowing it to offer an integrated "system of record plus system of action" platform combining TruBridge's EHR backbone with IKS Health's AI-driven care-enablement solutions.

IKS Health serves over 700 community and critical-access hospitals across the US and reported revenue of $347 million in calendar year 2025, according to regulatory disclosures. The company has a client base of more than 1,500 healthcare organisations and generates a significant portion of revenue from long-term software and service contracts.

Acquisition Financing

The acquisition will be funded primarily through debt, with IKS Inc. securing committed financing of up to $670 million from a consortium led by Citibank, JPMorgan Chase, and Deutsche Bank. The funding package includes a $610-million term loan, a $40-million secondary term loan, and a $20-million revolving credit facility. Initial leverage is expected to be around three times EBITDA of the combined entity, according to the investor presentation.

Read also: Hormuz Tensions Fuel Oil Price Surge: Key Market Indicators for April 24

Post-Acquisition Opportunities

Post-acquisition, the combined entity will serve over 2,000 healthcare organisations and 150,000 clinicians, with opportunities for cross-selling care-enablement solutions into TruBridge's installed base. The TruBridge deal builds on IKS Health's earlier acquisition of AQuity Solutions, which expanded its revenue cycle and clinical documentation services.

On Thursday, shares of IKS Health gained 0.55 percent on the BSE to close at Rs.1435.40, while the benchmark Sensex declined 1.09 percent to end at 77,664 points.